NVAX logo

Novavax (NVAX) Total liabilities

annual total liabilities:

$2.18B-$330.16M(-13.13%)
December 31, 2024

Summary

  • As of today (May 21, 2025), NVAX annual total liabilities is $2.18 billion, with the most recent change of -$330.16 million (-13.13%) on December 31, 2024.
  • During the last 3 years, NVAX annual total liabilities has fallen by -$744.17 million (-25.41%).
  • NVAX annual total liabilities is now -25.41% below its all-time high of $2.93 billion, reached on December 31, 2021.

Performance

NVAX Total liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVAXbalance sheet metrics

quarterly total liabilities:

$1.37B-$815.62M(-37.34%)
March 31, 2025

Summary

  • As of today (May 21, 2025), NVAX quarterly total liabilities is $1.37 billion, with the most recent change of -$815.62 million (-37.34%) on March 31, 2025.
  • Over the past year, NVAX quarterly total liabilities has dropped by -$851.98 million (-38.37%).
  • NVAX quarterly total liabilities is now -54.98% below its all-time high of $3.04 billion, reached on June 30, 2022.

Performance

NVAX quarterly total liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVAXbalance sheet metrics

Total liabilities Formula

Total Liabilities = Current Liabilities + Long-Term Liabilities

NVAX Total liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-13.1%-38.4%
3 y3 years-25.4%-50.6%
5 y5 years+508.5%+288.8%

NVAX Total liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-25.4%at low-55.0%at low
5 y5-year-25.4%+508.5%-55.0%+288.8%
alltimeall time-25.4%>+9999.0%-55.0%>+9999.0%

NVAX Total liabilities History

DateAnnualQuarterly
Mar 2025
-
$1.37B(-37.3%)
Dec 2024
$2.18B(-13.1%)
$2.18B(-2.4%)
Sep 2024
-
$2.24B(-0.5%)
Jun 2024
-
$2.25B(+1.3%)
Mar 2024
-
$2.22B(-11.7%)
Dec 2023
$2.51B(-13.1%)
$2.51B(+7.7%)
Sep 2023
-
$2.34B(-4.3%)
Jun 2023
-
$2.44B(+0.1%)
Mar 2023
-
$2.44B(-15.7%)
Dec 2022
$2.89B(-1.2%)
$2.89B(+2.1%)
Sep 2022
-
$2.83B(-6.8%)
Jun 2022
-
$3.04B(+9.8%)
Mar 2022
-
$2.77B(-5.4%)
Dec 2021
$2.93B(+206.6%)
$2.93B(+39.1%)
Sep 2021
-
$2.10B(+5.0%)
Jun 2021
-
$2.00B(+27.7%)
Mar 2021
-
$1.57B(+64.3%)
Dec 2020
$955.27M(+166.1%)
$955.27M(+14.1%)
Sep 2020
-
$837.58M(+12.0%)
Jun 2020
-
$747.70M(+112.4%)
Mar 2020
-
$352.04M(-1.9%)
Dec 2019
$358.97M(-4.5%)
$358.97M(+1.2%)
Sep 2019
-
$354.65M(-5.4%)
Jun 2019
-
$374.88M(+0.8%)
Mar 2019
-
$371.90M(-1.1%)
Dec 2018
$375.91M(-7.0%)
$375.91M(-0.3%)
Sep 2018
-
$377.16M(+1.0%)
Jun 2018
-
$373.51M(-0.5%)
Mar 2018
-
$375.44M(-7.1%)
Dec 2017
$404.23M(+1.1%)
$404.23M(-1.0%)
Sep 2017
-
$408.23M(-1.6%)
Jun 2017
-
$414.77M(+6.2%)
Mar 2017
-
$390.60M(-2.3%)
Dec 2016
$399.85M(+328.2%)
$399.85M(-2.4%)
Sep 2016
-
$409.84M(-1.2%)
Jun 2016
-
$414.89M(+1.9%)
Mar 2016
-
$407.07M(+336.0%)
Dec 2015
$93.37M(+101.3%)
$93.37M(+148.2%)
Sep 2015
-
$37.62M(+1.4%)
Jun 2015
-
$37.09M(-5.2%)
Mar 2015
-
$39.13M(-15.6%)
Dec 2014
$46.38M(+45.4%)
$46.38M(+50.3%)
Sep 2014
-
$30.86M(+2.0%)
Jun 2014
-
$30.26M(+9.9%)
Mar 2014
-
$27.54M(-13.6%)
Dec 2013
$31.89M(+44.3%)
$31.89M(+11.9%)
Sep 2013
-
$28.50M(+20.3%)
Jun 2013
-
$23.69M(+12.1%)
Mar 2013
-
$21.14M(-4.4%)
Dec 2012
$22.11M(+73.7%)
$22.11M(+15.3%)
Sep 2012
-
$19.17M(+20.6%)
Jun 2012
-
$15.90M(+11.1%)
Mar 2012
-
$14.31M(+12.5%)
Dec 2011
$12.73M(-19.4%)
$12.73M(+1.9%)
Sep 2011
-
$12.49M(-4.5%)
Jun 2011
-
$13.07M(-21.3%)
Mar 2011
-
$16.61M(+5.1%)
Dec 2010
$15.79M
$15.79M(+28.2%)
DateAnnualQuarterly
Sep 2010
-
$12.32M(+7.9%)
Jun 2010
-
$11.42M(-6.7%)
Mar 2010
-
$12.24M(-21.8%)
Dec 2009
$15.65M(-49.7%)
$15.65M(+76.6%)
Sep 2009
-
$8.86M(-34.3%)
Jun 2009
-
$13.50M(-55.3%)
Mar 2009
-
$30.17M(-3.1%)
Dec 2008
$31.14M(+10.3%)
$31.14M(-6.7%)
Sep 2008
-
$33.39M(-0.5%)
Jun 2008
-
$33.56M(+10.3%)
Mar 2008
-
$30.43M(+7.8%)
Dec 2007
$28.23M(+1.3%)
$28.23M(+1.4%)
Sep 2007
-
$27.82M(+0.2%)
Jun 2007
-
$27.78M(-1.8%)
Mar 2007
-
$28.28M(+1.4%)
Dec 2006
$27.88M(-19.7%)
$27.88M(+6.2%)
Sep 2006
-
$26.24M(-1.9%)
Jun 2006
-
$26.75M(+1.6%)
Mar 2006
-
$26.33M(-24.2%)
Dec 2005
$34.73M(-22.3%)
$34.73M(-14.6%)
Sep 2005
-
$40.64M(-2.3%)
Jun 2005
-
$41.60M(-1.4%)
Mar 2005
-
$42.18M(-5.7%)
Dec 2004
$44.71M(-7.3%)
$44.71M(+1.5%)
Sep 2004
-
$44.06M(-14.1%)
Jun 2004
-
$51.28M(+6.7%)
Mar 2004
-
$48.05M(-0.3%)
Dec 2003
$48.22M(-2.5%)
$48.22M(-1.1%)
Sep 2003
-
$48.73M(+2.0%)
Jun 2003
-
$47.79M(-1.1%)
Mar 2003
-
$48.34M(-2.2%)
Dec 2002
$49.43M(+24.8%)
$49.43M(+0.5%)
Sep 2002
-
$49.19M(-2.2%)
Jun 2002
-
$50.27M(+26.1%)
Mar 2002
-
$39.86M(+0.6%)
Dec 2001
$39.62M(+60.4%)
$39.62M(+2.0%)
Sep 2001
-
$38.83M(+38.2%)
Jun 2001
-
$28.10M(+16.8%)
Mar 2001
-
$24.06M(-2.6%)
Dec 2000
$24.70M(+1353.2%)
$24.70M(+1118.8%)
Sep 2000
-
$2.03M(+18.3%)
Jun 2000
-
$1.71M(+21.9%)
Mar 2000
-
$1.41M(-17.3%)
Dec 1999
$1.70M(+112.5%)
$1.70M(+70.0%)
Sep 1999
-
$1.00M(+233.3%)
Jun 1999
-
$300.00K(-66.7%)
Mar 1999
-
$900.00K(+12.5%)
Dec 1998
$800.00K(+166.7%)
$800.00K(+300.0%)
Sep 1998
-
$200.00K(-33.3%)
Jun 1998
-
$300.00K(0.0%)
Mar 1998
-
$300.00K(0.0%)
Dec 1997
$300.00K(-50.0%)
$300.00K(+50.0%)
Sep 1997
-
$200.00K(-60.0%)
Jun 1997
-
$500.00K(+25.0%)
Mar 1997
-
$400.00K(-33.3%)
Dec 1996
$600.00K
$600.00K(+50.0%)
Sep 1996
-
$400.00K(-20.0%)
Jun 1996
-
$500.00K(0.0%)
Mar 1996
-
$500.00K

FAQ

  • What is Novavax annual total liabilities?
  • What is the all time high annual total liabilities for Novavax?
  • What is Novavax annual total liabilities year-on-year change?
  • What is Novavax quarterly total liabilities?
  • What is the all time high quarterly total liabilities for Novavax?
  • What is Novavax quarterly total liabilities year-on-year change?

What is Novavax annual total liabilities?

The current annual total liabilities of NVAX is $2.18B

What is the all time high annual total liabilities for Novavax?

Novavax all-time high annual total liabilities is $2.93B

What is Novavax annual total liabilities year-on-year change?

Over the past year, NVAX annual total liabilities has changed by -$330.16M (-13.13%)

What is Novavax quarterly total liabilities?

The current quarterly total liabilities of NVAX is $1.37B

What is the all time high quarterly total liabilities for Novavax?

Novavax all-time high quarterly total liabilities is $3.04B

What is Novavax quarterly total liabilities year-on-year change?

Over the past year, NVAX quarterly total liabilities has changed by -$851.98M (-38.37%)
On this page